Specialty Pharmacy

Gadolinium-containing imaging agent could improve breast cancer survival.

Recent studies suggested that hepatitis C antiviral drugs may increase the risk of hepatocellular carcinoma.

The Drug Quality and Security Act provides a foundation for improving the safety of drug compounding by working with outsourcing facilities to meet regulatory standards.

In part 2, Beth Wallace describes the events leading up to her diagnosis with leiomyosarcoma.

Data from a phase 2 trial demonstrates positive results on improving the disabling symptoms of a rare form of autism.

Genentech is seeking approval for Perjeta used in combination with trastuzumab and chemotherapy for adjuvant treatment of HER2-positive early breast cancer.

Consolidative radiation followed by chemotherapy could play a key role in future survival outcomes among patients with non-small cell lung cancer.

Top news of the day from across the health care landscape.

New findings suggest alterations in this process may trigger cancer progression.

Top news of the week from Specialty Pharmacy Times.

Rebecca Shanahan, NASP president and CEO of Avella Specialty Pharmacy, announced the Distinguished Service Award and the Specialty Pharmacy of the Year Award.

Certified specialty pharmacists have greater opportunities and credibility in the growing market, according to a session at the annual NASP meeting.

The Improving Transparency and Accuracy in Medicare Part D Spending Act would end direct and indirect remuneration fees.

Top news of the day from across the health care landscape.

Inhibiting neuroligin-3 in mice delayed the proliferation of high-grade glioma.

The 3-in-1 antibody protected laboratory monkeys from SHIV.

FDA advisory committee votes the data was inconclusive on ataluren (translarna), a first-in-class oral treatment for Duchenne muscular dystrophy.

In part 1 of 2, Beth Wallace shares her journey leading up to her diagnosis with leiomyosarcoma.

Verzenio can be administered as a stand-alone treatment to patients previously treated with endocrine therapy and chemotherapy.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Ron Lanton III, Esq, discusses all things biosimilar during a session at the National Association of Specialty Pharmacy (NASP) Annual Meeting and Educational Conference.

Direct and indirect remuneration fees have inflicted harm on specialty pharmacies and the patients they treat.

Promotion of healthy lifestyle changes are crucial among HIV-positive patients cured of hepatitis C.

Top news of the day from across the health care landscape.

Alex M. Azar II, JD, discusses problems with the Affordable Care Act and the spread of misinformation surrounding drug costs during a session at the National Association of Specialty Pharmacy Annual Meeting and Educational Conference.

Sen Bill Cassidy, MD, spoke about the need for health care reform and the value of the specialty pharmacy at this year’s National Association of Specialty Pharmacy Annual Meeting and Educational Conference.

AbbVie grants commercialization rights to Amjevita.

The award goes to the organization that has done the most to advance patient care and the practice of specialty pharmacy.

New classes of multiple sclerosis medications are improving on disease suppression.

Capturing the correct patient data can enhance current specialty pharmacy programs to drive unparalleled care.